Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Yes, families can help track Alzheimer’s treatment effects—often in ways that clinicians miss. A family member who lives with someone or sees them regularly observes behavior patterns over days and weeks: whether a person is sleeping better after starting a new medication, whether the afternoon confusion is worse on certain days, whether someone is more withdrawn or more agitated. A neurologist sees that same person for 15 minutes every three months. The family sees them at breakfast, during medication time, in moments of frustration, during good hours and bad hours. That continuous observation is clinical data. The catch is that families need structure.
Casual observations—”Dad seems better” or “Mom had a bad day”—don’t tell a doctor what changed. Specific, dated notes do. A medication started on June 1st, and by June 8th the person’s nighttime confusion dropped from seven times a week to three? That’s actionable. A vague sense that someone is doing well after a treatment adjustment doesn’t help a doctor decide whether to continue it, adjust the dose, or try something else. Families already do this work in fragments. The goal is making it purposeful and organized enough that it actually shapes treatment decisions.
Table of Contents
- WHAT KINDS OF CHANGES CAN FAMILIES OBSERVE?
- THE LIMITATIONS OF FAMILY OBSERVATION
- WHEN FAMILY TRACKING SHAPES TREATMENT DECISIONS
- HOW TO TRACK TREATMENT EFFECTS EFFECTIVELY
- WHEN FAMILY TRACKING CAN GO WRONG
- INVOLVING THE DOCTOR IN FAMILY TRACKING
- WHAT DOCTORS CAN DO TO MAKE FAMILY TRACKING MORE RELIABLE
WHAT KINDS OF CHANGES CAN FAMILIES OBSERVE?
Families typically notice three categories of change that matter for treatment tracking: cognition, behavior, and physical effects. Cognitive changes are the most direct to document. Is the person asking the same question repeatedly more or less often? Can they remember conversations from yesterday? Are they orienting better to time and place? These questions have yes-or-no answers that shift over time. A wife keeping a log might note “Tuesday—called me three times asking what we’re doing for dinner” versus “Friday—asked once, seemed to understand my answer.” The change is concrete and measurable by a non-clinician.
Behavioral and mood changes require more interpretation but are still observable. A person who starts a medication and becomes less agitated, or less withdrawn, shows a measurable shift. The risk is that families attribute changes to the medication when they might be due to a change in routine, the season, a urinary tract infection, or sleep deprivation. An adult child might think a parent is responding to treatment when the person is actually reacting to having a caregiver around more often. Families need to be careful about jumping to conclusions, but the underlying observation—”Mom is calmer than she was last month”—is valid data.
THE LIMITATIONS OF FAMILY OBSERVATION
Family members are not trained observers, and they have blind spots. The most common problem is that families normalize changes gradually. If someone’s memory declines slowly over months, family members may not consciously register it because they adjust their communication day by day. A spouse stops expecting her husband to remember appointments and stops asking him about them. The cognitive decline happened, but the family didn’t see it as a sudden shift—they just adapted. When a doctor later asks “Has his memory gotten worse since we started the medication?” the family might say no, simply because they’ve accommodated the problem. Stress and fatigue also distort family observations.
A caregiver who has not slept well or who is overwhelmed may interpret any small improvement as major progress, or may feel so defeated that they focus only on things that are still wrong. One research study found that family members’ ratings of cognitive improvement after a dementia treatment often differed significantly from objective test scores. The family wasn’t lying—they were reacting emotionally to a situation, which is human, but it’s not the same as precise measurement. Timing and cause-and-effect are particularly tricky. If a person seems better after starting a medication but also started a new day program, or had a visit from a grandchild, families may not know which factor helped. Doctors run controlled trials to isolate variables precisely because real life is messy. A family keeping casual notes may miss that complexity.
WHEN FAMILY TRACKING SHAPES TREATMENT DECISIONS
families have the most influence over treatment adjustments when they report specific, repeated observations that doctors can’t easily test. Neuropsychiatric symptoms—agitation, aggression, wandering, sleep problems—are classic examples. A doctor can’t watch someone sleep at home. They can’t see how many times a person wanders or how difficult they are to redirect. A family reporting “He gets agitated every afternoon, and it’s gotten worse since we increased the dose” gives the doctor information that matters for deciding whether to continue, adjust, or stop that medication. Consider this scenario: a person with mid-stage Alzheimer’s starts an antipsychotic medication. Two weeks later, the family reports that the person is calmer, less combative with caregivers, sleeping at night.
The behavior symptoms have improved. But the family also notices the person seems more confused than before, doesn’t engage with conversation, and looks drowsy. That person’s quality of life might actually be worse even though the targeted symptom improved. A family tracking both the good and the concerning changes provides the doctor with a complete picture. Some doctors would choose to reduce the dose or switch medications based on that input. Others might not. But the family’s careful observation changed what the doctor knew and could consider.
HOW TO TRACK TREATMENT EFFECTS EFFECTIVELY
The most useful family tracking involves a simple log with date, behavior or symptom, and context. A checklist is easier than a narrative, but a few concrete details are better than a rating scale. Instead of marking “mood: better/same/worse,” a note like “Tuesday—made a joke at dinner, first time in two weeks” is more useful. Instead of “confusion: 7/10,” a note like “Tuesday—got lost trying to find the bathroom, which is in the same hallway as his bedroom” shows the specificity doctors need. Many families use a notebook, a phone note app, or a simple shared spreadsheet. Some doctors’ offices provide printed logs or digital forms. The barrier isn’t technology—it’s time.
Tracking takes a few minutes a day, and not every family member has capacity for that. A version that works is one that actually gets used. If a caregiver will spend two minutes on a checklist but won’t spend five minutes on detailed notes, the checklist is the right tool. Imperfect data that exists is more useful than perfect data that never gets recorded. A practical comparison: one family tracks medication timing and sleep quality every morning for a month, noting “took pill at 7 a.m., slept 7 hours, woke once” or “took pill at 7 a.m., slept 5 hours, woke three times.” A different family keeps a handwritten log of all behaviors and moods throughout the week. The first family’s log is easier to scan for patterns. A doctor can see in five seconds that sleep improved on nights when the medication timing didn’t change but the dose did. The second family’s detailed log might be richer, but it’s harder to draw conclusions from unless the family also summarizes it.
WHEN FAMILY TRACKING CAN GO WRONG
One major risk is that families conflate correlation with causation. Someone starts a new Alzheimer’s medication, and a week later the family notices the person seems more alert. The family attributes the alertness to the medication. But what if the person also started physical therapy that week, or a visiting nurse began coming daily, or a family member retired and can now spend more time together? The real cause of improvement might not be the drug at all. Families need to be aware that other things change, even if they don’t intend for them to. Another risk is that tracking becomes a source of stress or resentment.
If one family member is assigned the responsibility of keeping the log and feels burdened by it, they may stop doing it, or do it resentfully, or record only the bad days because those are most vivid in their mind. Shared responsibility and realistic expectations help. If keeping a detailed daily log is not feasible, a weekly summary or a note each time something significant changes is better than abandonment and guilt. A warning sign that family tracking has become unreliable is when the same family member is reporting both the symptoms and the person’s response to treatment. If one adult child is saying “Mom’s confusion is worse” and also saying “But we started the new medication so we’ll give it a few more weeks,” that person’s observations may be shaped by hope or investment in the medication choice. A second opinion from another family member, a caregiver, or a healthcare provider can help ground observations in reality.
INVOLVING THE DOCTOR IN FAMILY TRACKING
Most neurologists and geriatricians welcome family observations if they’re organized. Some offices have standing templates or ask families to bring a log to each appointment. Others don’t ask because they assume families won’t track. A family can bring up the topic directly: “I’ve been keeping notes on how Mom’s been doing each week. Would it help if I shared those with you before the next appointment?” Even a simple email with key observations before an appointment helps. A message like “Since we started the medication on June 1st, I’ve noticed the afternoon confusion is less frequent. She’s asking me the same questions maybe 3-4 times a day instead of 8-10.
But she seems more tired in the evenings” gives the doctor concrete data to discuss. That takes the appointment from being reactive—the doctor asks how things are going, the family gives a general impression—to being informed. The doctor can ask whether the tiredness is a side effect worth managing, or whether that’s actually an improvement if it means she’s sleeping better at night. Some families find it valuable to ask the doctor at the start of a new treatment what specific signs to watch for. Instead of tracking everything, the family focuses on what matters most. A doctor starting someone on a medication for apathy might say “Let’s see if she’s initiating activities more often” and give the family one thing to observe. That narrows the focus and makes tracking more manageable.
WHAT DOCTORS CAN DO TO MAKE FAMILY TRACKING MORE RELIABLE
Clinicians can improve family observations by being clear about what matters. Instead of a vague “Let me know if you notice any changes,” a doctor can say “This medication sometimes causes drowsiness in the first week, and it usually improves after that. Watch for whether he’s hard to wake in the morning or sleeping much more. Also notice whether the agitation is less frequent.” That specificity helps families separate signal from noise. Some doctors use formal rating scales with families—the same brief questionnaire at each visit. The family answers the same questions in the same way, and the doctor can track change numerically. This reduces the subjective interpretation.
The downside is that standardized scales can miss what matters most to that specific family, and they take time to administer. A practical example: one neurology clinic gives families a one-page form with 12 common symptoms, asking them to rate each on a scale of 0 to 3 monthly. The family fills it out before each appointment. The doctor reviews it in the waiting room. In five minutes, the doctor has three months of data on sleep, appetite, behavior, engagement, and confusion. That structured approach has limitations—it misses nuances—but it’s reliable and efficient. Families consistently use it because it’s quick, and doctors find it useful because they can compare month to month.
- —
